COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning -
-
-
COMMUNIQUÉ DE PRESSE
Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business
Gerresheimer sees revenue growth in H1 2025, driven by Bormioli Pharma acquisition. Subdued demand in cosmetics and oral liquids market. Positive long-term outlook despite challenges -
COMMUNIQUÉ DE PRESSE
Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
Formycon completes patient enrollment for clinical development of Keytruda biosimilar FYB206. Results expected in Q1 2026. Streamlined program accelerates development -
COMMUNIQUÉ DE PRESSE
SenseRobot Debuts at AI for Good Global Summit 2025, Showcasing China's AI Innovations to the World
SenseRobot President Mark Ma presented at the United Nations AI for Good Global Summit 2025, showcasing China's AI innovation. The session highlighted AI's role in enhancing human learning, family bonds, and inclusion -
COMMUNIQUÉ DE PRESSE
Début de SenseRobot au L’IA au service du bien Sommet mondial 2025 : une vitrine des innovations chinoises en matière d’intelligence artificielle à l’échelle mondiale
SenseRobot présente ses avancées en IA lors du Sommet mondial 2025, soulignant son rôle dans l'apprentissage humain, les liens familiaux et l'inclusion
